Onat H - Search Results

1

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy.

Alici S, Bavbek S, Basaran M, Onat H. Alici S, et al. Among authors: onat h. Adv Ther. 2006 Jul-Aug;23(4):534-42. doi: 10.1007/BF02850042. Adv Ther. 2006. PMID: 17050496

2

Prognostic factors and survival in late adolescent and adult patients with small round cell tumors.

Eralp Y, Bavbek S, Başaran M, Kaytan E, Yaman F, Bilgiç B, Darendeliler E, Onat H. Eralp Y, et al. Among authors: onat h. Am J Clin Oncol. 2002 Aug;25(4):418-24. doi: 10.1097/00000421-200208000-00020. Am J Clin Oncol. 2002. PMID: 12151977

3

Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors.

Alici S, Bavbek SE, Kaytan E, Başaran M, Eralp Y, Onat H. Alici S, et al. Among authors: onat h. Am J Clin Oncol. 2002 Oct;25(5):502-8. doi: 10.1097/00000421-200210000-00016. Am J Clin Oncol. 2002. PMID: 12393993

4

Prognostic factors in localized aggressive non-Hodgkin's lymphoma.

Alici S, Bavbek SE, Kaytan E, Eralp Y, Onat H. Alici S, et al. Among authors: onat h. Am J Clin Oncol. 2003 Feb;26(1):1-5. doi: 10.1097/00000421-200302000-00001. Am J Clin Oncol. 2003. PMID: 12576915

5

Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.

Argon A, Basaran M, Yaman F, Dizdar Y, Sakar B, Camlica H, Bavbek SE, Ozger H, Darendeliler E, Onat H. Argon A, et al. Among authors: onat h. Jpn J Clin Oncol. 2004 Nov;34(11):667-72. doi: 10.1093/jjco/hyh122. Jpn J Clin Oncol. 2004. PMID: 15613556

6

Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: single center experience from Turkey.

Ustuner Z, Basaran M, Dizdar Y, Agaoglu FY, Bilgic B, Sakar B, Basaran GA, Darendeliler E, Ozger H, Onat H, Bavbek S. Ustuner Z, et al. Among authors: onat h. Tohoku J Exp Med. 2007 Nov;213(3):221-9. doi: 10.1620/tjem.213.221. Tohoku J Exp Med. 2007. PMID: 17984619 Free article.

7

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.

Basaran M, Bavbek ES, Sakar B, Eralp Y, Alici S, Tas F, Yaman F, Dogan O O, Camlica H, Onat H. Basaran M, et al. Among authors: onat h. Am J Clin Oncol. 2001 Dec;24(6):570-5. doi: 10.1097/00000421-200112000-00008. Am J Clin Oncol. 2001. PMID: 11801756 Clinical Trial.

8

Survival outcomes in aggressive non-Hodgkin's lymphoma according to the International Prognostic Index.

Alici S, Bavbek SE, Kaytan E, Basaran M, Bulutlar G, Onat H. Alici S, et al. Among authors: onat h. J BUON. 2003 Apr-Jun;8(2):121-6. J BUON. 2003. PMID: 17472237

9

Relapse of non-Hodgkin's lymphoma confined to the corpus uteri.

Yazar A, Basaran M, Yaman F, Dizdar Y, Tuzlali S, Bavbek S, Onat H. Yazar A, et al. Among authors: onat h. Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):273-4. doi: 10.1111/j.1479-828X.2004.00218.x. Aust N Z J Obstet Gynaecol. 2004. PMID: 15191460 No abstract available.

10

A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.

Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. Basaran M, et al. Among authors: onat h. Oncology. 2007;72(3-4):255-60. doi: 10.1159/000113017. Epub 2008 Jan 10. Oncology. 2007. PMID: 18185020 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters